MET
37
-3
PSX
34
-6
JCI
46
2
OI
50
4
NOC
40
11
THC
65
-3
TMO
54
-2
EQR
56
2
CPB
47
2
NI
51
3
RCL
57
-2
PSA
43
11
MMC
53
2
BDX
46
11
EXC
63
2
DG
32
2
AAP
35
6
JWN
53
5
MHK
46
12
BXP
38
4
MET
37
-3
PSX
34
-6
JCI
46
2
OI
50
4
NOC
40
11
THC
65
-3
TMO
54
-2
EQR
56
2
CPB
47
2
NI
51
3
RCL
57
-2
PSA
43
11
MMC
53
2
BDX
46
11
EXC
63
2
DG
32
2
AAP
35
6
JWN
53
5
MHK
46
12
BXP
38
4
Financhill
Back

Gilead Sciences 10K Form

Sell
28

GILD
Gilead Sciences

Last Price:
66.74
Seasonality Move:
6.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-02-23 10K GILD/Gilead Sciences Annual
2023-11-07 10Q GILD/Gilead Sciences Quarterly
2023-08-04 10Q GILD/Gilead Sciences Quarterly
2023-05-03 10Q GILD/Gilead Sciences Quarterly
2023-02-22 10K GILD/Gilead Sciences Annual
2022-11-02 10Q GILD/Gilead Sciences Quarterly

Receive GILD News And Ratings

See the #1 stock for the next 7 days that we like better than GILD

GILD Financial Statistics

Sales & Book Value

Annual Sales: $27.12B
Cash Flow: $1.95B
Price / Cash Flow: 11.21
Annual Sales: $18.32
Price / Book: 3.61

Profitability

EPS (TTM): 4.50000
Net Income (TTM): $5.66B
Gross Margin: $20.62B
Return on Equity: 26.17%
Return on Assets: 9.08%

Gilead Sciences Earnings Forecast

Key Gilead Sciences Financial Ratios

  • The Gross Profit Margin over the past 33 years for GILD is 76.04%.
  • The Selling, General & Administrative Expenses for GILD have been equal to 22.46% of Gross Profit Margin.
  • The Research & Development expenses have been 21.09% of Revenue.
  • The Interest Expense is 16.66% of Operating Income.
  • The Net Earning history of GILD is 20.89% of Total Revenues.
  • Per Share Earnings over the last 33 years have been positive in 19 years.

Gilead Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Biotechnology
Sector: Health Care
Current Symbol: GILD
CUSIP: 375558
Website: gilead.com

Debt

Debt-to-Equity Ratio: 1.09
Current Ratio: 1.43
Quick Ratio: 1.06

Price-to-Earnings

Trailing P/E Ratio: 14.7
Forward P/E Ratio: 9.03

GILD Technical Analysis vs Fundamental Analysis

Sell
28
Gilead Sciences (GILD) is a Sell

Is Gilead Sciences a Buy or a Sell?

  • Gilead Sciences stock is rated a Sell
    The current Gilead Sciences [GILD] share price is $66.16. The Score for GILD is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.